Patients taking tirzepatide may experience yeast infections due to underlying factors related to their diabetes rather than the medication itself
Managing Expectations: Realistic Timelines Setting appropriate expectations prevents disappointment and supports long-term adherence
Written informed consent for participation was obtained from the participants in accordance with the national legislation and institutional requirements
The most commonly reported adverse effects are gastrointestinal, including nausea, diarrhoea, vomiting, and constipation
Lets break down what these medications do, how they work in your body, and what you need to know about insurance coverage
At the earliest, a negotiated price for Semaglutide (Wegovy) would not be available for Medicare and Part D enrollees before 2027 and not before 2031 for Tirzepatide (Zepbound)